Nouveau Life Pharmaceuticals, Inc.

Nouveau Life Pharmaceuticals, Inc.

NOUV - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$666.1K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Nouveau Life Pharmaceuticals, Inc.Nouveau Life Pharmaceuticals, Inc.0-161%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$666,096.00
Enterprise Value$658,383.00
Earnings per Share$-0.01
Beta-0.49
Outstanding Shares6,660,963,733

Return

Return on Equity160.52%ROE
Return on Assets-1988.54%
Return on Invested Capital-3224.54%

Valuation & Multiples

P/E Ratio-0.01P/E Ratio
PEG0.06PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-3.46
Enterprise Value to Net Income-5
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Nouveau Life Pharmaceuticals, Inc.

0
CEO: Brian Shibley

Nouveau Life Pharmaceuticals, Inc. (NOUV) is a company in its developmental stage, primarily focused on crafting nutraceutical products. It offers both natural health solutions and pharmaceutical drugs. The entity, which began operations...